Ken Griffin Prokidney Corp Ord Shs Cl A(Cy Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Citadel Advisors LLC holds 76,600 shares of PROK stock, worth $153,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares

76,600

Previous 6,100 1155.74%

Holding current value

$153,200

Previous $10,000 1780.0%

% of portfolio

0.0%

Previous 0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.2 - $1.76 $10,224 - $14,995	-8,520 Reduced 58.29%	6,096 $9,000
Q4 2023 Feb 14, 2024	BUY	$1.21 - $4.76 $17,685 - $69,572	14,616 New	14,616 $26,000
Q2 2023 Aug 14, 2023	BUY	$9.0 - $13.0 $8,100 - $11,700	900 New	900 $10,000

Others Institutions Holding PROK

# of Institutions

Shares Held

40M

Call Options Held

644K

Put Options Held

118K

View Full List

About PROKIDNEY CORP ORD SHS CL A(CY

Ticker PROK
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,540,200
Market Cap $123M

More about PROK

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account